Voloridge Investment Management, LLC Spectrum Pharmaceuticals Inc Transaction History

Voloridge Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$2.11 - $3.38 $105,196 - $168,513	-49,856 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $91,236 - $172,003	49,856 New	49,856 $116,000
Q4 2019 Feb 14, 2020	SELL	$3.5 - $10.35 $132,650 - $392,265	-37,900 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$7.03 - $9.7 $163,060 - $224,991	-23,195 Reduced 37.97%	37,900 $314,000
Q2 2019 Aug 14, 2019	SELL	$7.36 - $11.26 $55,089 - $84,281	-7,485 Reduced 10.91%	61,095 $526,000
Q1 2019 May 15, 2019	BUY	$9.08 - $11.84 $622,706 - $811,987	68,580 New	68,580 $733,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.